Free Trial

Tapestry (TPR; Baa2, BBB+; double Neg) {TPR US Equity} {CPRI US Equity}

CONSUMER CYCLICALS

Few updates below, none impact our view on the € lines; only screen cheap for those with minimal funding/carry costs now. 60% chance of deal failing priced in equities.


  • Moody's was out affirming Tapestry at Baa2, on review for downgrade. Re. Capri it expects stabilisation in the earnings fall over next 12-18 months - somewhat in-line with current consensus that's looking for -3.5% fall in 4Q24 (-7.5% over the year) followed by mild +2% growth in FY25. We expect Moody's to stabilise outlook if deal doesn't close. It does note the forced call clause on bonds.
  • Bloomberg surveyed 20 M&A specialist for downside on capri equities (i.e. on deal not closing); year-end prices generally sat at $20-25 vs. current $36 & takeover $57. That's in line with back of the hand math; ~30% slide in forward EPS against a flat forward P/E ratio of mid 5's (which it was trading at pre-deal) leaves mid to low $20s. Current share price implies a 60% chance for deal failing.
  • Equity analyst views we've seen still seem skewed to closing but have been moving lower/lagging Capri equities. Legal experts quoted on the media seem uncertain this early on.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.